|Bid||82.28 x 1300|
|Ask||82.55 x 800|
|Day's Range||82.13 - 83.47|
|52 Week Range||55.36 - 90.61|
|Beta (5Y Monthly)||0.80|
|PE Ratio (TTM)||14.67|
|Earnings Date||Aug 04, 2021|
|Forward Dividend & Yield||2.00 (2.43%)|
|Ex-Dividend Date||Jul 22, 2021|
|1y Target Est||94.90|
CVS Health's (CVS) consumer-centric digital approach to administer vaccines across the nation is expected to have strongly contributed to its Q2 performance within retail segment.
UNH stock has crafted a shapely cup-with-handle base pattern, even as it's outrun the market so far this year. Here is what analysis says about buying UNH stock.
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.